Most digital communications are secured by encryption built on mathematical problems so hard that conventional computers cannot realistically solve them. That…
Targeted cancer therapies are increasingly being paired with immunotherapy and chemotherapy to improve outcomes across multiple tumor types First-in-class PP2A…
Frontieras notes milestone moment: groundbreaking of facility based on a new industrial model built on extracting the full value of…
Canadian scientists have made an unexpected finding about glioblastoma, one of the deadliest and hardest-to-treat forms of brain cancer. Cells previously regarded as passive…
For a long time, proton therapy wasn’t available for many cancer patients due to the footprint of traditional proton therapy…
Stanford University scientists developed a molecular urine analysis that can distinguish bladder cancer patients who need immunotherapy from those already…
The global train collision avoidance system market is expected to reach $13.32 billion by 2030, growing at a compound annual…
Frontieras is developing breakthrough technologies that convert abundant solid hydrocarbons such as coal into cleaner fuels, hydrogen and industrial energy…
LIXT is advancing its lead compound LB-100 across different clinical programs aimed at difficult-to-treat cancers The company’s acquisition of Liora…
The National Transportation Safety Board (“NTSB”) has intensified its focus on collision-prevention technologies following multiple rail incidents. Rail Vision’s proprietary…